Rational therapeutic approach to cardiogenic shock.
D000925:Anticoagulants / Q000627:therapeutic use; D001784:Blood Gas Analysis; D001810:Blood Volume; D006328:Cardiac Catheterization; D004298:Dopamine / Q000627:therapeutic use; D004562:Electrocardiography; D005934:Glucagon / Q000627:therapeutic use; D006321:Heart / Q000503:physiopathology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007545:Isoproterenol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology; D010100:Oxygen / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D012039:Regional Blood Flow; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology; D014481:United States; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000925:Anticoagulants; D014662:Vasoconstrictor Agents; D005934:Glucagon; D007545:Isoproterenol; D010100:Oxygen; D004298:Dopamine